Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic review

Blank
Al-Azhar University – Gaza
Hammed A.; Al-Qiami A.; Hasan A.; Richter G.; Zakria Alnajjar A.; Rosenbauer J.; Kostev K.; Ismail O.; Braun V.; Tanislav C.
Hammed, Ali (57222273991); Al-Qiami, Almonzer (58732317000); Hasan, Ali (59945588700); Richter, Gregor (59382999500); Zakria Alnajjar, Asmaa (59945012500); Rosenbauer, Josef (57780528100); Kostev, Karel (25637745400); Ismail, Omar (59763592500); Braun, Veit (7201814509); Tanislav, Christian (57826980200)
57222273991; 58732317000; 59945588700; 59382999500; 59945012500; 57780528100; 25637745400; 59763592500; 7201814509; 57826980200
2025
Therapeutic Advances in Neurological Disorders
Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic review
18
SAGE Publications Ltd
1.75628642513435E+016
Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany; Faculty of Medicine and Health Sciences, Kassala University, P.O. Box 1266, Kassala, 21111, Sudan; Department of Oncology and Palliative Care, Helios Klinikum Bad Saarow, Brandenburg, Germany; Department of Neuroradiology, Diakonie Hospital Jung Stilling, Siegen, Germany; Faculty of Medicine, Al-Azhar University, Gaza, Palestine; University Hospital, Philipps University Marburg, Marburg, Germany; Department of Neurosurgery, Diakonie Hospital Jung Stilling, Siegen, Germany
Hammed A., Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany; Al-Qiami A., Faculty of Medicine and Health Sciences, Kassala University, P.O. Box 1266, Kassala, 21111, Sudan; Hasan A., Department of Oncology and Palliative Care, Helios Klinikum Bad Saarow, Brandenburg, Germany; Richter G., Department of Neuroradiology, Diakonie Hospital Jung Stilling, Siegen, Germany; Zakria Alnajjar A., Faculty of Medicine, Al-Azhar University, Gaza, Palestine; Rosenbauer J., Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany; Kostev K., University Hospital, Philipps University Marburg, Marburg, Germany; Ismail O., Department of Neuroradiology, Diakonie Hospital Jung Stilling, Siegen, Germany; Braun V., Department of Neurosurgery, Diakonie Hospital Jung Stilling, Siegen, Germany; Tanislav C., Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany
A. Al-Qiami; Faculty of Medicine and Health Sciences, Kassala University, Kassala, P.O. Box 1266, 21111, Sudan; email: almonzer.m.o.ahmed@kassalauni.edu.sd
1
10.1177/17562864251343574
Bevacizumab; re-irradiation; recurrent glioblastoma
bevacizumab; Article; cancer radiotherapy; cancer survival; demographics; drug efficacy; drug safety; gene mutation; glioblastoma; glioma; human; irradiation; Karnofsky Performance Status; meta analysis; outcome assessment; overall survival; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; progression free survival; randomized controlled trial (topic); risk assessment; sensitivity analysis; systematic review